Cardiovascular and renovascular implications of COX-2 inhibition.
D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects* / Q000201:enzymology; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis; D016896:Treatment Outcome
D016861:Cyclooxygenase Inhibitors; D011453:Prostaglandins